Cerebrolysin Side Effects: Safety Signals and Warnings
Cerebrolysin safety concerns are compound-specific. The main listed side effects are Headache, Dizziness, and Injection site pain. The main warning signals are Contraindicated in epilepsy and status epilepticus (may lower seizure threshold), Contraindicated in severe renal impairment, and Derived from porcine tissue - contraindicated in patients with pork allergies.
Direct Answer
Cerebrolysin has the most substantial clinical evidence base of any nootropic peptide complex in this library - multiple Phase 3 RCTs from European and Asian research groups, including positive results in acute ischemic stroke, vascular dementia, and Alzheimer's disease. The fact that it is a porcine brain extract (not a defined single molecule) complicates regulatory classification, but the controlled trial evidence is real and reproducible across independent groups.
- Evidence grade
- Level B
- Research status
- Phase 3
- Category
- Cognitive & Nootropic
- Best for
- Acute ischemic stroke recovery, vascular dementia, Alzheimer's disease adjunct, neuroprotection research
Reported Side Effects
- Headache
- Dizziness
- Injection site pain
- Nausea
- Agitation
- Insomnia
- Hyperhidrosis
Warnings
- Contraindicated in epilepsy and status epilepticus (may lower seizure threshold)
- Contraindicated in severe renal impairment
- Derived from porcine tissue - contraindicated in patients with pork allergies
- Not approved by FDA; approved in over 40 other countries
Known or Plausible Interactions
- MAO inhibitors (risk of hypertensive crisis)
- Antidepressants (potential serotonergic interactions)
- Antiepileptic drugs (may alter seizure threshold)
Regulatory Context
Prescription medication in Europe, Russia, Asia, and Latin America; not FDA-approved in the United States.
Evidence Snapshot
| Evidence grade | Level B |
|---|---|
| Research status | Phase 3 |
| Best supported outcomes | Stroke Recovery (Level B), Alzheimer Disease Cognition (Level B), and Traumatic Brain Injury (Level C) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "Cerebrolysin Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/cerebrolysin-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.